Published in Br J Pharmacol on September 01, 1982
Trace amine-associated receptor 1-Family archetype or iconoclast? Pharmacol Ther (2007) 1.72
Animal behavioral methods in neurotoxicity assessment: SGOMSEC joint report. Environ Health Perspect (1996) 0.81
Neuropharmacological and neurochemical properties of N-(2-cyanoethyl)-2-phenylethylamine, a prodrug of 2-phenylethylamine. Br J Pharmacol (1987) 0.78
Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophan. J Neurochem (1971) 3.34
Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia (1967) 2.66
Serotonergic component of neuroleptic receptors. Nature (1978) 1.74
An animal behavior model for studying central serotonergic synapses. Life Sci (1976) 1.47
The contribution of tryptamine to the behavioural effects of l-Tryptophan in tranylcypromine-treated rats. Psychopharmacology (Berl) (1978) 1.45
Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain. J Pharmacol Exp Ther (1973) 1.29
The role of brain dopamine in the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Neuropharmacology (1974) 1.26
(-)-Propranolol inhibits the behavioural responses of rats to increased 5-hydroxytryptamine in the central nervous system. Nature (1976) 1.26
Role of tryptaminergic mechanisms in the elements of the behavioural syndrome evoked by tryptophan and a monoamine oxidase inhibitor [proceedings]. Br J Pharmacol (1977) 1.22
Blockade of 5-hydroxytryptamine receptors in the central nervous system by beta-adrenoceptor antagonists. Neuropharmacology (1977) 1.19
Specificity of a rat behavioral model for serotonin receptor activation. J Pharmacol Exp Ther (1978) 1.16
Indoleamine antagonists: relative potencies as inhibitors of tryptamine- and 5-hydroxytryptophan-evoked responses. Br J Pharmacol (1974) 1.10
Does phenylethylamine cause schizophrenia? Lancet (1976) 1.02
Phenylethylamine hypothesis of affective behavior. Am J Psychiatry (1974) 1.01
Kinetic measurements of the turnover rates of phenylethylamine and tryptamine in vivo in the rat brain. J Neurochem (1980) 1.01
A behavioural and biochemical study in rats of 5-hydroxytryptamine receptor agonists and antagonists, with observations on structure-activity requirements for the agonists. Br J Pharmacol (1981) 0.95
Some arylalkylamines in rabbit brain. Brain Res (1975) 0.95
Identification and distribution of beta-phenylethylamine in the rat. Can J Biochem (1973) 0.93
Different hypothalamic receptors mediate 5-hydroxytryptamine- and tryptamine-induced core temperature changes in the rat. Br J Pharmacol (1981) 0.92
FORMATION OF BETA-PHENYLETHYLAMINE IN MAMMALIAN TISSUE AND ITS EFFECT ON MOTOR ACTIVITY IN THE MOUSE. J Pharmacol Exp Ther (1964) 0.91
Phenylethylamine in paranoid chronic schizophrenia. Science (1979) 0.90
[3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain. J Pharmacol Exp Ther (1981) 0.87
The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation. Eur J Pharmacol (1975) 0.87
Separation, detection and quantitative analysis of urinary beta-phenylethylamine. J Chromatogr (1971) 0.85
The effects of acute and chronic administration of beta-phenylethylamine on food intake and body weight in rats. Prog Neuropsychopharmacol (1981) 0.85
Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine. J Pharm Pharmacol (1976) 0.84
Metabolism distribution, and disappearance of injected beta-phenylethylamine in the rat. Can J Biochem (1975) 0.83
Serotonin-sensitive adenylate cyclase and [3H]serotonin binding sites in the CNS of the rat--I. Biochem Pharmacol (1980) 0.83
Evidence for the presence of m-tyramine, p-tyramine, tryptamine, and phenylethylamine in the rat brain and several areas of the human brain. Biol Psychiatry (1978) 0.82
A new animal model for schizophrenia: interactions with adrenergic mechanisms. Biol Psychiatry (1978) 0.81
The differential neurochemical bases of the behaviours elicited by serotonergic agents and by the combination of a monoamine oxidase inhibitor and L-DOPA. Neuropharmacology (1981) 0.81
Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate. Proc Natl Acad Sci U S A (1978) 0.81
A comparison of the responses of cortical neurones to iontophoretically applied tryptamine and 5-hydroxytryptamine in the rat. Neuropharmacology (1982) 0.79
Changes in drug-induced stereotyped behavior after 6-OHDA lesions in noradrenaline neurons. Psychopharmacology (Berl) (1977) 0.78
Dose-response effects of beta-phenylethylamine on stereotyped behavior in pargyline-pretreated rats. Biol Psychiatry (1976) 0.78
Behavioural effects of acute and chronic beta-phenylethylamine administration in the rat: evidence for the involvement of 5-hydroxytryptamine. Neuropharmacology (1981) 0.78
Chronic phenylethylamine stereotypy in rats: a new animal model for schizophrenia? Life Sci (1977) 0.77
The effect of -phenethylamine upon spontaneous motor activity in mice: a dual effect on locomotor activity. J Pharm Pharmacol (1972) 0.77
Differential antagonism by neuroleptics of backward-walking and other behaviours caused by amphetamine at high dosage. Neuropharmacology (1980) 0.77
Some further observations of the effect of beta-phenethylamine on locomotor activity in mice. J Pharm Pharmacol (1975) 0.76
DOPA and other naturally occurring substances as causes of stereotypy and rage in rats. Acta Psychiatr Scand Suppl (1966) 0.76
The involvement of noradrenergic systems in the locomotor activity stimulation in mice produced by beta-phenethylamine. J Pharm Pharmacol (1974) 0.76
Interaction of metergoline with striatal dopamine system. Life Sci (1978) 0.76
Behavioural and pharmacological characterisation of the elevated "zero-maze" as an animal model of anxiety. Psychopharmacology (Berl) (1994) 2.33
Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT1A receptor antagonist. Behav Brain Res (1996) 1.74
Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats. Psychopharmacology (Berl) (2003) 1.61
Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice. Psychopharmacology (Berl) (1999) 1.47
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry (2001) 1.19
Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety. Neurosci Biobehav Rev (1998) 1.17
Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist and d-fenfluramine on feeding patterns in the rat. Psychopharmacology (Berl) (2000) 1.13
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology (2001) 1.12
Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease. Neurology (2003) 1.11
Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat. Psychopharmacology (Berl) (1985) 1.03
Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression. Eur J Pharmacol (1987) 0.96
The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats. Br J Pharmacol (1988) 0.95
The role of CCK caerulein, and CCK antagonists in nociception. Pain (1989) 0.95
Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action. Eur J Pharmacol (1987) 0.94
5-HT1B agonists induce anorexia at a postsynaptic site. Eur J Pharmacol (1987) 0.93
Silent 5-HT1A receptor antagonists: utility as research tools and therapeutic agents. Trends Pharmacol Sci (1993) 0.92
Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats. Psychopharmacology (Berl) (1997) 0.90
Indoline derivatives as 5-HT(2C) receptor agonists. Bioorg Med Chem Lett (2004) 0.90
Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats. Br J Pharmacol (2000) 0.89
The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women. J Psychopharmacol (2008) 0.89
Oral administration of the 5-HT2Creceptor agonist, mCPP, reduces body weight gain in rats over 28 days as a result of maintained hypophagia. Psychopharmacology (Berl) (2003) 0.89
Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Psychopharmacology (Berl) (1986) 0.88
8-OH-DPAT-induced hyperphagia: its neural basis and possible therapeutic relevance. Appetite (1986) 0.88
Cholecystokinin and anxiety. Trends Pharmacol Sci (1990) 0.88
Effects of ET 495 (piribedil) on water intake in the rat: evidence for a dopaminergic involvement in thirst. Ir J Med Sci (1978) 0.87
Dissociation between cognitive and motor/motivational deficits in the delayed matching to position test: effects of scopolamine, 8-OH-DPAT and EAA antagonists. Psychopharmacology (Berl) (1995) 0.87
An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats. Psychopharmacology (Berl) (1994) 0.86
Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats. Psychopharmacology (Berl) (1991) 0.86
Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse. Psychopharmacology (Berl) (2006) 0.85
The effects of acute and chronic administration of beta-phenylethylamine on food intake and body weight in rats. Prog Neuropsychopharmacol (1981) 0.85
Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study. Eur J Pharmacol (1993) 0.85
Measurement of anxiety in transgenic mice. Rev Neurosci (2000) 0.84
Effects of the 5-HT2C receptor agonist meta-chlorophenylpiperazine on appetite, food intake and emotional processing in healthy volunteers. Psychopharmacology (Berl) (2014) 0.84
Effects of 5-HT1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat. Psychopharmacology (Berl) (1996) 0.84
Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse. Neurosci Lett (1987) 0.84
Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats. Psychoneuroendocrinology (1988) 0.84
Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT). Brain Res Bull (1985) 0.84
Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.84
Effects of the novel anxiolytics gepirone, buspirone and ipsapirone on free feeding and on feeding induced by 8-OH-DPAT. Psychopharmacology (Berl) (1987) 0.83
Evidence that the hyperphagic response to 8-OH-DPAT is mediated by 5-HT1A receptors. Eur J Pharmacol (1988) 0.83
Bilateral lesions of the striatum induced with 6-hydroxydopamine abolish apomorphine-induced yawning in rats. Neuropharmacology (1985) 0.82
CCK-A receptors in the rat interpeduncular nucleus: evidence for a presynaptic location. Brain Res (1988) 0.81
Comparisons between the effects of 5-HT and DL-fenfluramine on food intake and gastric emptying in the rat. Pharmacol Biochem Behav (1995) 0.81
The effects of ketamine and risperidone on eye movement control in healthy volunteers. Transl Psychiatry (2013) 0.81
Pharmacological characterization of the behavioural syndrome induced by the NK-3 tachykinin agonist senktide in rodents: evidence for mediation by endogenous 5-HT. Brain Res (1990) 0.81
The role of catecholamines, 5-hydroxytryptamine and m-tyramine in the behavioural effects of m-tyrosine in the rat. Eur J Pharmacol (1982) 0.80
Blockade of pre- and post-synaptic 5-HT1A receptors does not modify the effect of fluoxetine or 5-hydroxytryptophan on ethanol and food intake in rats. Psychopharmacology (Berl) (1997) 0.80
Neurochemical and behavioural evidence for mediation of the hyperphagic action of 8-OH-DPAT by 5-HT cell body autoreceptors. Eur J Pharmacol (1986) 0.80
Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. Br J Pharmacol (1990) 0.80
Hypolocomotion induced by peripheral or central injection of CCK in the mouse is blocked by the CCKA receptor antagonist devazepide but not by the CCKB receptor antagonist L-365,260. Eur J Pharmacol (1991) 0.80
Role of dopamine D-1 and D-2 receptor subtypes in mediating dopamine agonist effects on food consumption in rats. Psychopharmacology (Berl) (1988) 0.79
Case series: amantadine open-label treatment of impulsive and aggressive behavior in hospitalized children with developmental disabilities. J Am Acad Child Adolesc Psychiatry (2001) 0.79
mCPP-induced hyperactivity in 5-HT2C receptor mutant mice is mediated by activation of multiple 5-HT receptor subtypes. Neuropharmacology (2004) 0.79
Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra. Psychopharmacology (Berl) (1987) 0.79
5-HT2C receptor modulation and the treatment of obesity. Diabetes Obes Metab (1999) 0.78
Dopaminergic involvement in the control of drinking behaviour: a brief review. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.78
Alterations in working memory networks in amnestic mild cognitive impairment. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2014) 0.78
Behavioural effects of acute and chronic beta-phenylethylamine administration in the rat: evidence for the involvement of 5-hydroxytryptamine. Neuropharmacology (1981) 0.78
CCK antagonists and CCK-monoamine interactions in the control of satiety. Am J Clin Nutr (1992) 0.78
Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat. Psychopharmacology (Berl) (1985) 0.77
Devazepide attenuates dl-fenfluramine-induced suppression of gastric emptying but not food intake in the 17 h food-deprived rat. Physiol Behav (1997) 0.77
Effects of the putative 5-HT1A receptor antagonist NAN-190 on free feeding and on feeding induced by the 5-HT1A receptor agonist 8-OH-DPAT in the rat. Eur J Pharmacol (1992) 0.77
Behavioural evidence that d-fenfluramine-induced anorexia in the rat is not mediated by the 5-HT1A receptor subtype. Psychopharmacology (Berl) (1996) 0.77
The influence of 5-hydroxytryptamine re-uptake blockade on CCK receptor antagonist effects in the rat elevated zero-maze. Eur J Pharmacol (1994) 0.77
Environmental experience produces qualitative changes in the stimulant effects of beta-phenylethylamine in rats. Psychopharmacology (Berl) (1984) 0.77
Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635. Eur J Pharmacol (1994) 0.77
Effects of acute or chronic administration of low doses of a dopamine agonist on drinking and locomotor activity in the rat. Psychopharmacology (Berl) (1981) 0.76
Benefits of ethological analysis of behaviour. Trends Pharmacol Sci (1995) 0.76
Blockade of CCK-B receptors by L-365,260 induces analgesia in the squirrel monkey. Brain Res (1990) 0.76
WAY100635 and latent inhibition in the rat: selective effects at preexposure. Behav Brain Res (1997) 0.76
The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat. Neuroscience (1994) 0.76
Local application of beta-phenylethylamine to the caudate nucleus of the rat elicits locomotor stimulation. Pharmacol Biochem Behav (1985) 0.76
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation. Psychopharmacology (Berl) (1988) 0.76
Differential aversive stimulus properties of beta-phenylethylamine and of d-amphetamine. Psychopharmacology (Berl) (1984) 0.75
MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype. Neurosci Lett (1989) 0.75
In vivo characterization of the putative 5-HT1A receptor antagonist SDZ 216,525 using two models of somatodendritic 5-HT1A receptor function. Neuropharmacology (1994) 0.75
Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory. Psychopharmacology (Berl) (1996) 0.75
Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329. Neuropharmacology (1989) 0.75
Sedation, stereotypy and the inhibition of drinking after administration of ET 495 in the rat [proceedings]. Br J Pharmacol (1979) 0.75
Lack of interaction between devazepide and 8-OH-DPAT-induced hyperphagia in the rat. Physiol Behav (1996) 0.75
Deuterium substitution enhances the effects of beta-phenylethylamine on spontaneous motor activity in the rat. Pharmacol Biochem Behav (1983) 0.75
Effects of ageing on the behavioural responses to dopamine agonists: decreased yawning and locomotion, but increased stereotypy. Brain Res (1989) 0.75
The effects of CCKA and CCKB antagonists on activity in the black/white exploration model of anxiety in mice. Physiol Behav (1993) 0.75
Potentiation of total horizontal activity and ambulation in rats treated with combinations of beta-phenylethylamine and naloxone. Neuropharmacology (1984) 0.75
Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications. Biochem Soc Trans (1991) 0.75
Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding. Physiol Behav (1990) 0.75
The role of 5-HT1B receptors in the paraventricular nucleus of the hypothalamus in the control of feeding. Neurobiol Aging (1989) 0.75
Biphasic behavioural stimulation induced by a monoamine oxidase-inhibiting antidepressant. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.75
Effects of the selective 5-HT1A receptor antagonist WAY100135 and its enantiomers on 8-OH-DPAT-induced hyperglycaemia in conscious rats. Eur J Pharmacol (1994) 0.75
Fluoxetine reduces food intake by a cholecystokinin-independent mechanism. Pharmacol Biochem Behav (1990) 0.75
Pharmacological and biochemical analysis of feeding behaviour. Brain Res Bull (1985) 0.75
Hypodipsia, stereotypy and hyperactivity induced by beta-phenylethylamine in the water-deprived rat. Pharmacol Biochem Behav (1984) 0.75
Behavioural and neurochemical effects of meta-tyrosine in the rat. Prog Neuropsychopharmacol Biol Psychiatry (1982) 0.75
Effects of piribedil and of d-amphetamine on locomotor activity in immature rats. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.75
Pharmacology of beta-phenylethylamine-induced seizures in mice. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.75
Potentiation of the behavioural effects of the antidepressant phenelzine by deuterium substitution. Psychopharmacology (Berl) (1983) 0.75
Putative PEA receptors? Psychiatry Res (1982) 0.75
Alterations in trace amine and trace acid concentrations in isolated aggressive mice. Pharmacol Biochem Behav (1982) 0.75
Monitoring 5HT metabolism in the brain of the freely moving rat. Ann N Y Acad Sci (1986) 0.75
Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190. Eur J Pharmacol (1995) 0.75